wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28390181-4982185F-98C5-4E81-8F2A-9C8C39E3B3C0
Q28390181-4982185F-98C5-4E81-8F2A-9C8C39E3B3C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28390181-4982185F-98C5-4E81-8F2A-9C8C39E3B3C0
Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting
P2860
Q28390181-4982185F-98C5-4E81-8F2A-9C8C39E3B3C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28390181-4982185F-98C5-4E81-8F2A-9C8C39E3B3C0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5cd63289c665e4cee5b2f344b1f059df2f2ca33e
P2860
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.